Rockland CEO Appears on Money Matters

Date Posted:

Jim Fendrick, President and CEO of Rockland Immunochemicals, recently offered insight into the antibody industry and its role in the world of Biotechnology in September 2012 on Money Matters. Jim spoke with co-hosts Charlie Huntington of BioStrategy partners and Kimon Hatza, Esq. of MillCrest Law, LLP on the impact that new antibody technology is having throughout the biotechnology sector.

For more information and to watch the episode, visit